Ziff Capital Partners is a venture capital firm and family office that was founded after the Ziff Family closed their United States and London, United Kingdom based hedge funds in 2014. Founded by Dirk Ziff, the eldest brother of the third-generation Ziff brothers (Daniel, Robert and Dirk), Ziff Capital Partners is based in New York City. Co-founder of the firm, Nicholas Seaver, is the Managing Director, in charge of fundamental value orientation, deal sourcing, due diligence, sector analysis and investment strategy. Ziff Capital Partners implements a fundamental long-short investing with a variety of sector exposures to technology and energy.
Invested $26M in Platelet BioGenesis.
A biotechnology company in Massachusetts that focuses on developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.
Dirk Edward Ziff